2024 Annual Meeting | H260 - Operationalizing, Diagnostics and Treatments in Alzheimer's (Innovation Hub)
Program Materials Program Evaluations
| 01:15 PM - 02:15 PM MDT | Speaker |
Operationalizing, Diagnostics and Treatments in Alzheimer's (Innovation Hub)
David A. Evans, MBA, Christine Mann, MBA |
| David A. Evans, MBA | Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon Therapeutics. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for NeuroNet GPO. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroNet Pro. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. |
| Christine Mann, MBA | Ms. Mann has nothing to disclose. |